Director Sloan Jeffrey Steven sold 3,600 shares of CPAY at $343.62, reducing holdings by 22.4% to 12,474 shares for $1.2M total value.
Director Sloan Jeffrey Steven executed a discretionary sale of 3,600 shares on 2026-02-17 at $343.62, representing a 22.4% reduction in his total holdings from 16,074 to 12,474 shares. The sale occurred at a price roughly 1.5% below the current market price of $349.19 and within the 52-week trading range, reflecting no exceptional valuation timing. CORPAY trades at a P/E of 23.23 with solid fundamentals—annual revenue growth of 5.8% and quarterly revenues of $1,172,480,000.00—indicating a mature, profitable business with modest growth momentum. The stock has appreciated significantly in recent periods, posting +8.9% over 30 days and +25.9% over 90 days, yet remains 9.7% below its 52-week high.